Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triapine in Recurrent Renal Cell Carcinoma
NCT00075660Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- May 2004
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triapine in renal cell carcinoma (RCC), sponsored by Canadian Cancer Trials Group. Started May 2004; status: completed.
02
Drugs
triapine
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00075660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075660.